Bullish Moving Averages
3
Bearish Moving Averages
13
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
5960.00Today’s High
6027.7052W low
4410.2052W High
6874.40Open Price
6000.00Prev. Close
6023.1500Volume
582216.00Value
3498885273.60Fundamentals
Market Cap Cr
86408.90
Price to Earnings
109.50
Price to Book Value
13.20
Dividend Yield
0.20
PE to Growth
34.00
Op Revenue TTM Cr
18417.50
Net Profit TTM Cr
789.32
Cash From Operating Activity Cr
1376.70
Return on Equity %
13.21
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 May, 2024
65.9
Week
45.1
Month
45.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
5999.12
PIVOT
First Resistance
6038.18
Second Resistance
6066.77
Third Resistance
6105.83
First Support
5970.53
Second Support
5931.47
Third Support
5902.88
Relative Strength Index
41.41
Money Flow Index
27.18
MACD
-71.91
MACD Signal
-32.39
Average True Range
159.83
Average Directional Index
19.74
Rate of Change (21)
-6.93
Rate of Change (125)
24.68
Commodity Channel Index
-121.5
Williams %R
-62.9
BETA
1 Month
0.54
3 Month
0.6
1 Year
0.34
3 Year
0.05
PRICE CHANGE ANALYSIS
↓ -3.98%
1 Week
Low
High
5733
6200
↓ -6.69%
1 Month
Low
High
5733
6540
↓ -4.92%
3 Months
Low
High
5733
6874.45
↑ 16.62%
6 Months
Low
High
5087.45
6874.45
↑ 31.99%
1 Year
Low
High
4410.25
6874.45
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1875.80 | 1931.10 | 1706.20 | 1683.60 | 1694.05 | 1758.49 | 1540.21 | 1439.39 | 2857.99 | 2831.49 | 3003.45 | |
| Operating Expenses Qtr | 1374.00 | 1387.40 | 1270.70 | 1217.63 | 1221.86 | 1262.51 | 1141.35 | 1088.68 | 2421.76 | 2384.34 | 2604.12 | |
| Operating Profit Qtr | 450.30 | 479.10 | 417.70 | 423.20 | 416.88 | 453.07 | 388.34 | 332.05 | 424.41 | 438.86 | 390.59 | |
| EBIDT Qtr Cr | 501.80 | 543.70 | 435.50 | 465.97 | 472.19 | 495.98 | 398.86 | 355.63 | 436.23 | 447.15 | 392.59 | |
| Depreciation Qtr | 97.20 | 93.40 | 93.10 | 96.69 | 88.86 | 91.99 | 89.15 | 104.70 | 97.41 | 93.73 | 96.00 | |
| Net Profit Qtr | 262.80 | 294.80 | 214.10 | 226.86 | 245.59 | 279.19 | 333.14 | 153.67 | 175.41 | 185.89 | 150.04 | |
| Basic EPS Qtr | 18.28 | 20.50 | 14.89 | 15.78 | 17.08 | 19.42 | 23.17 | 10.69 | 12.20 | 12.93 | 10.44 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 6676.30 | 6145.30 | 9171.10 | 9805.30 | 8348.90 | |
| Operating Expenses Annual Cr | 4843.30 | 4678.90 | 8205.70 | 8379.10 | 7318.51 | |
| Operating Profit Annual | 1681.50 | 1419.40 | 947.30 | 1415.30 | 1018.14 | |
| Operating Profit Margin Annual % | 25.19 | 23.10 | 10.33 | 14.43 | 12.19 | |
| Total Expenses Annual Cr | 5448.80 | 5286.30 | 8985.40 | 9287.30 | 7886.43 | |
| EBIDT Annual Cr | 1833.00 | 1466.40 | 965.40 | 1426.20 | 1030.38 | |
| EBIDT Annual margin % | 27.46 | 23.86 | 10.53 | 14.55 | 12.34 | |
| Depreciation | 366.70 | 363.40 | 435.90 | 482.30 | 299.89 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1084.80 | 572.50 | 105.00 | 470.30 | 302.76 | |
| Net Profit Annual | 1084.80 | 665.20 | 105.00 | 470.30 | 302.76 | |
| Basic EPS Annual | 75.45 | 46.25 | 7.50 | 33.80 | 21.76 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 6924.80 | 6110.70 | 5201.50 | 3988.40 | 3883.42 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 2612.30 | 3108.30 | 3006.40 | 4212.80 | 2911.85 | |
| Total Current Liabilities Annual Cr | 1243.30 | 1189.20 | 1521.30 | 1943.00 | 1633.08 | |
| Total Capital Plus Liabilities Annual Cr | 10780.40 | 10408.20 | 9729.20 | 10144.20 | 8428.35 | |
| Fixed Assets Annual | 5174.40 | 5144.60 | 5257.20 | 6282.30 | 4788.62 | |
| Total Non Current Assets Annual | 7629.70 | 6953.00 | 6691.50 | 7829.20 | 6425.33 | |
| Total Current Assets Annual | 3150.70 | 3455.20 | 3037.70 | 2315.00 | 2003.02 | |
| Total Assets Annual | 10780.40 | 10408.20 | 9729.20 | 10144.20 | 8428.35 | |
| Contingent Liabilities plus Commitments Annual Cr | 928.80 | 863.40 | 1452.40 | 868.80 | 1065.38 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1224.50 | 1201.00 | 915.40 | 1096.10 | 907.27 | |
| Cash from Investing Activity Annual | -588.50 | -444.80 | -764.70 | -263.90 | -775.56 | |
| Cash from Financing Annual Activity | -778.60 | -637.20 | -175.40 | -770.70 | -159.69 | |
| Net Cash Flow Annual | -142.60 | 119.00 | -24.70 | 61.50 | -27.98 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 481.56 | 424.94 | 361.72 | 286.52 | 279.13 | |
| ROE Annual % | 15.66 | 10.88 | 2.01 | 11.79 | 7.79 | |
| ROCE Annual % | 15.37 | 11.96 | 6.45 | 11.50 | 10.74 | |
| Total Debt to Total Equity Annual | 0.25 | 0.33 | 0.38 | 0.74 | 0.79 | |
| EBDIT Annual Margin % | 28.09 | 24.04 | 10.54 | 14.56 | 12.35 |
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 4878.40 | 4869.10 | 4446.00 | 4318.55 | 4298.94 | 4273.64 | 3811.66 | 3577.15 | 3656.08 | 3722.70 | 3784.85 | |
| Operating Expenses Qtr | 4236.90 | 4219.40 | 3908.80 | 3814.05 | 3758.23 | 3685.70 | 3304.86 | 3083.19 | 3051.91 | 3102.08 | 3240.34 | |
| Operating Profit Qtr | 613.70 | 627.50 | 509.00 | 488.15 | 505.35 | 565.37 | 490.74 | 463.24 | 587.02 | 614.99 | 519.87 | |
| EBIDT Qtr Cr | 641.50 | 651.60 | 537.20 | 504.50 | 540.71 | 587.94 | 506.80 | 493.96 | 604.17 | 620.62 | 838.62 | |
| Depreciation Qtr | 167.00 | 163.40 | 166.90 | 159.06 | 153.39 | 155.01 | 147.78 | 166.40 | 148.99 | 144.76 | 140.56 | |
| Net Profit Qtr | 245.30 | 232.90 | 166.60 | 144.52 | 153.46 | 203.99 | 317.11 | 90.14 | 228.37 | 247.82 | 489.28 | |
| Basic EPS Qtr | 17.06 | 16.20 | 11.59 | 10.05 | 10.67 | 14.19 | 22.05 | 6.27 | 15.88 | 17.24 | 34.03 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 16702.80 | 14740.80 | 10605.00 | 11273.70 | 9648.88 | |
| Operating Expenses Annual Cr | 14562.90 | 12477.50 | 9422.60 | 9659.50 | 8553.78 | |
| Operating Profit Annual | 2049.60 | 2185.10 | 1137.40 | 1587.30 | 1063.66 | |
| Operating Profit Margin Annual % | 12.27 | 14.82 | 10.73 | 14.08 | 11.02 | |
| Total Expenses Annual Cr | 15559.10 | 13456.80 | 10444.90 | 10812.00 | 9276.32 | |
| EBIDT Annual Cr | 2139.90 | 2263.30 | 1182.40 | 1614.20 | 1095.10 | |
| EBIDT Annual margin % | 12.81 | 15.35 | 11.15 | 14.32 | 11.35 | |
| Depreciation | 615.40 | 600.70 | 573.10 | 619.70 | 395.52 | |
| PAT Before ExtraOrdinary Items Annual Cr | 887.50 | 1101.10 | 136.00 | 434.80 | 199.19 | |
| Net Profit Annual | 819.10 | 1055.60 | 150.40 | 454.80 | 236.05 | |
| Basic EPS Annual | 56.97 | 73.42 | 10.74 | 32.70 | 16.97 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 6197.40 | 5623.30 | 4602.50 | 3339.10 | 3333.47 | |
| Minority Interest Liability Annual Cr | 333.90 | 254.40 | 199.90 | 130.70 | 135.46 | |
| Total Non Current Liabilities Annual Cr | 4571.60 | 4931.40 | 4576.40 | 5531.30 | 3758.76 | |
| Total Current Liabilities Annual Cr | 3324.90 | 2383.30 | 2037.90 | 2337.30 | 1955.38 | |
| Total Capital Plus Liabilities Annual Cr | 14427.80 | 13192.40 | 11416.70 | 11338.40 | 9183.07 | |
| Fixed Assets Annual | 8143.90 | 7391.40 | 6636.90 | 7321.50 | 5457.18 | |
| Total Non Current Assets Annual | 10090.80 | 9070.80 | 7775.50 | 8691.60 | 6901.34 | |
| Total Current Assets Annual | 4337.00 | 4121.60 | 3641.20 | 2646.80 | 2281.73 | |
| Total Assets Annual | 14427.80 | 13192.40 | 11416.70 | 11338.40 | 9183.07 | |
| Contingent Liabilities plus Commitments Annual Cr | 732.40 | 658.10 | 1636.00 | 651.60 | 836.01 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1376.70 | 1628.00 | 1273.40 | 1292.80 | 904.95 | |
| Cash from Investing Activity Annual | -870.60 | -778.20 | -872.30 | -288.80 | -710.56 | |
| Cash from Financing Annual Activity | -633.00 | -792.60 | -340.10 | -909.50 | -214.51 | |
| Net Cash Flow Annual | -126.90 | 57.20 | 61.00 | 94.50 | -20.12 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 454.19 | 408.74 | 333.96 | 249.27 | 249.34 | |
| ROE Annual % | 13.21 | 18.77 | 3.26 | 13.62 | 7.08 | |
| ROCE Annual % | 13.73 | 15.38 | 6.49 | 11.04 | 9.67 | |
| Total Debt to Total Equity Annual | 0.44 | 0.47 | 0.54 | 1.00 | 1.03 | |
| EBDIT Annual Margin % | 12.88 | 15.43 | 11.19 | 14.35 | 11.38 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC TRUSTEE COMPANY LIMITED | 3.84 | 74201917 | - | - |
| AXIS MUTUAL FUND TRUSTEE LIMITED | 1.81 | 74201918 | - | - |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED | 1.35 | 74201920 | - | - |
| GOVERNMENT OF SINGAPORE | 2.14 | 74201929 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 1.28 | 74201931 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Ms. Suneeta Reddy | 3.36 | 74201891 | 48.51 | 0 |
| Ms. Sangita Reddy | 1.69 | 74201892 | 0 | 0 |
| Ms. Shobana Kamineni | 1.56 | 74201893 | 0 | 0 |
| Mr. K Vishweshwar Reddy | 1.1 | 74201894 | 58.01 | 0 |
| Ms. Preetha Reddy | 0.73 | 74201895 | 0 | 0 |
| M/s. PCR Investments Ltd | 18.93 | 74201912 | 12.95 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC TRUSTEE COMPANY LIMITED | 3.84 | 74201917 |
| AXIS MUTUAL FUND TRUSTEE LIMITED | 1.81 | 74201918 |
| SBI NIFTY 50 ETF | 1.5 | 74201919 |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED | 1.35 | 74201920 |
| NIPPON LIFE INDIA TRUSTEE LTD | 1.04 | 74201921 |
| GOVERNMENT OF SINGAPORE | 2.14 | 74201929 |
| SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES | 1.64 | 74201930 |
| GOVERNMENT PENSION FUND GLOBAL | 1.28 | 74201931 |
| LIFE INSURANCE CORPORATION OF INDIA | 1.58 | 74201923 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 20, 2024 | 6 | INTERIM | Feb 20, 2024 | Equity Share |
| Aug 18, 2023 | 9 | FINAL | Aug 19, 2023 | Equity Share |
| Feb 24, 2023 | 6 | FINAL | Feb 24, 2023 | Equity Share |
| Aug 18, 2022 | 11.75 | FINAL | - | Equity Share |
| Aug 18, 2021 | 3 | FINAL | - | Equity Share |
| Sep 17, 2020 | 2.75 | FINAL | - | Equity Share |
| Feb 25, 2020 | 3.25 | INTERIM | Feb 26, 2020 | Equity Share |
| Sep 12, 2019 | 6 | FINAL | - | Equity Share |
| Sep 12, 2018 | 5 | FINAL | - | Equity Share |
| Sep 07, 2017 | 6 | FINAL | - | Equity Share |
| Mar 22, 2016 | 6 | INTERIM | Mar 23, 2016 | Equity Share |
| Jul 30, 2015 | 5.75 | FINAL | - | Equity Share |
| Aug 13, 2014 | 5.75 | FINAL | - | Equity Share |
| Jul 25, 2013 | 5.5 | FINAL | - | Equity Share |
| Jul 26, 2012 | 4 | FINAL | - | Equity Share |
| Jul 07, 2011 | 3.75 | FINAL | - | Equity Share |
| Jul 15, 2010 | 7 | FINAL | - | Equity Share |
| Aug 20, 2009 | 6.5 | FINAL | - | Equity Share |
| Aug 11, 2008 | 6 | FINAL | - | Equity Share |
| Aug 09, 2007 | 2 | FINAL | - | Equity Share |
| Mar 22, 2007 | 3 | INTERIM | Mar 24, 2007 | Equity Share |
| Jul 27, 2006 | 4.5 | FINAL | - | Equity Share |
| Jul 29, 2005 | 4 | FINAL | - | Equity Share |
| Aug 30, 2004 | 3.5 | FINAL | - | Equity Share |
| Aug 11, 2003 | 3 | FINAL | - | Equity Share |
| Sep 02, 2002 | - | FINAL | - | Equity Share |
| Aug 17, 2001 | - | FINAL | - | Equity Share |
| Aug 22, 2000 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Sep 02, 2010 | 10:5 | 2010-09-03 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 30, 2024 | Audited Results & Final Dividend | - |
| Feb 08, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 09, 2023 | Quarterly Results | - |
| Aug 11, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results & Final Dividend | - |
| Feb 14, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 30, 2022 | Others | Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis. |
| Nov 10, 2022 | Quarterly Results | - |
| Aug 11, 2022 | Quarterly Results | - |
| May 25, 2022 | Audited Results & Dividend | - |
| Feb 11, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 23, 2021 | Audited Results & Dividend | - |
| Feb 12, 2021 | Quarterly Results | - |
| Jan 22, 2021 | Others | inter alia, consider and determine the issue price of Equity Shares to be issued pursuant to the QlP. |
| Nov 11, 2020 | Quarterly Results | - |
| Sep 14, 2020 | Quarterly Results | - |
| Jun 25, 2020 | Audited Results | (Revised) |
| Jun 22, 2020 | Audited Results | - |
| Feb 13, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Dividend | - |
| Feb 09, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 10, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Dividend | - |
| Feb 14, 2018 | Quarterly Results | - |
| Nov 13, 2017 | Quarterly Results | - |
| Aug 14, 2017 | Quarterly Results | - |
| May 30, 2017 | Audited Results & Dividend | - |
| Feb 14, 2017 | Quarterly Results & Others | - |
| Nov 11, 2016 | Quarterly Results | - |
| Oct 07, 2016 | Others | Allotment of 3000 secured Redeemable Non-Convertible Debentures of face value of Rs. 10 lakhs each aggregating to Rs. 300 crores to Institutional Investors/Banks/Financial Institutions. |
| Oct 04, 2016 | Others | Approve the issue of rated, listed, secured Redeemable Non-Convertible Debentures on a private placement basis to be listed on the wholesale debt market segment of the National Stock Exchange. |
| Sep 01, 2016 | Quarterly Results | - |
| May 25, 2016 | Audited Results | The Board of Directors considered and confirmed the interim dividend declared at its meeting held on March 15, 2016 and paid to the shareholders on March 29, 2016. |
| Mar 15, 2016 | Interim Dividend | - |
| Feb 12, 2016 | Quarterly Results | - |
| Nov 14, 2015 | Quarterly Results | - |
| Aug 11, 2015 | Quarterly Results | - |
| May 28, 2015 | Audited Results & Dividend | Proposal for further issue of equity shares on a Rights basis, to the existing shareholders of the Company. |
| Feb 14, 2015 | Quarterly Results | - |
| Nov 12, 2014 | Quarterly Results | - |
| Aug 12, 2014 | Quarterly Results | - |
| May 28, 2014 | Audited Results & Dividend | - |
| Feb 10, 2014 | Quarterly Results | - |
| Nov 12, 2013 | Quarterly Results | - |
| Aug 07, 2013 | Quarterly Results | - |
| May 20, 2013 | Audited Results & Dividend | - |
| Feb 07, 2013 | Quarterly Results | - |
| Nov 09, 2012 | Quarterly Results | - |
| Aug 10, 2012 | Quarterly Results | - |
| May 29, 2012 | Audited Results & Dividend | - |
| Feb 10, 2012 | Quarterly Results | - |
| Nov 04, 2011 | Quarterly Results | - |
| Aug 10, 2011 | Quarterly Results | - |
| May 24, 2011 | Audited Results & Dividend | - |
| Feb 11, 2011 | Quarterly Results | - |
| Dec 09, 2010 | Allotment of Equity Shares | For allotment of 1,140,992 Equity Shares to the International Finance Corporation, Washington DC at a price of Rs. 302.50 per Equity Share of Rs. 5/- each upon part conversion of FCCB loan amount. |
| Nov 09, 2010 | Quarterly Results | - |
| Aug 12, 2010 | Quarterly Results & Others | To determine the eligible Shareholders of the Company, to receive the sub-divided Equity Shares of face value of Rs. 5/- each in the place of existing Equity Shares of face value of Rs. 10/- each. |
| May 28, 2010 | Stock split | The Board has approved the sub-division of each existing Equity Share of nominal value of Rs. 10/- each into 2 Equity Shares of nominal value of Rs. 5/- each, subject to approval of members. |
| Apr 30, 2010 | Issue of Convetible Warrants | To issue upto 1,544,621 Warrants Conv. into Equity Shares to Dr. Prathap C. Reddy, with each Warrant Conv. into one Equity Share of the Co. of NV of Rs. 10/- each at a price of Rs. 771.76 per Share. |
| Jan 28, 2010 | Quarterly Results & Others | For allotment of 1500 Unsecured Foreign Currency Convertible Bonds of face value of USD 10,000 each aggregating to USD 15 million to International Finance Corporation, Washington. |
| Oct 29, 2009 | Quarterly Results | - |
| Jul 18, 2009 | Quarterly Results | - |
| Jun 29, 2009 | Audited Results, Dividend & Others | To issue of FCCB' s, subject to regarding approvals being obtained, including approval of the members of the Co. for a value up to USD 15,000,000 to International Finance Corporation ("IFC"). |
| Jan 30, 2009 | Quarterly Results | - |
| Oct 30, 2008 | Quarterly Results & Stock Split | inter alia, to drope the proposal of sub-division of each existing equity share of Rs 10/- each into 10 (Ten) equity shares of Re 1/- each. |
| Jul 31, 2008 | Quarterly Results | - |
| Jun 24, 2008 | Audited Results & Dividend | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 23, 2007 | Quarterly Results | - |
| Jul 23, 2007 | Quarterly Results | - |
| Jun 26, 2007 | Audited Results & Final Dividend | - |
| Mar 16, 2007 | Interim Dividend | - |
| Jan 24, 2007 | Quarterly & Half Yearly Results | - |
| Jan 05, 2007 | To consider issue of Warrants | To issue up to 1,550,000 warrants convertible into equity shares of Rs 10/- each on preferential allotment basis to Ms. Sangita Reddy. |
| Nov 22, 2006 | Half Yearly Results | - |
| Jul 25, 2006 | Quarterly Results | - |
| Jun 12, 2006 | Accounts & Dividend | - |
| May 12, 2006 | To raise long term resources | - |
| Jan 30, 2006 | Quarterly Results | - |
| Dec 12, 2005 | Proposal to acquire new hospital | To consider interalia the proposal to acquire new hospital. |
| Nov 25, 2005 | Half Yearly Results | - |
| Nov 04, 2005 | Others | To consider a proposal to purchase 100% of equity capital of Samudra Healthcare Enterprises Ltd, Kakinanda, Andhra Pradesh, an unlisted public limited Company. |
| Jul 25, 2005 | Quarterly Results | - |
| Jun 03, 2005 | Allotment of share warrants | The Board has approved the allotment of 1,039,965 Share Warrants to the specified promoters convertible into Equity Shares within 18 months from the date of allotment i.e. December 02, 2006. |
| May 23, 2005 | Accounts & Dividend | - |
| Apr 18, 2005 | Preferential issue of warrants | 1. Further issue of Equity Shares / Depository Receipts / Convertible Shares Warrants / FCCB on preferential basis. 2. Preferential issue of warrants & equity shares. |
| Jan 18, 2005 | Quarterly Results | - |
| Nov 16, 2004 | Half Yearly Results | - |
| Jul 30, 2004 | Others | Issue of equity shares up to a maximum of 5% of paid up capital on private placement basis. |
| Jun 25, 2004 | Dividend & Accounts | - |
| Jan 22, 2004 | Quarterly Results | - |
| Jul 21, 2003 | Quarterly Results | - |
| Jun 25, 2003 | Accounts & Dividend | - |
| Jan 28, 2003 | Quarterly Results | - |
| Nov 28, 2002 | Half Yearly Results | - |
| Jul 30, 2002 | Quarterly Results | - |
| Jun 17, 2002 | Accounts & Dividend | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 23, 2002 | Quarterly Results | - |
| Nov 30, 2001 | Half Yearly Results | (Revised) |
| Oct 27, 2001 | Scheme of Demerger | Scheme of Demerger of Clinic Division run by Apollo Mumbai Hospital Ltd. into the company |
| Jul 31, 2001 | Quarterly Results | - |
| Jun 11, 2001 | Accounts | - |
| Jan 25, 2001 | Quarterly Results | - |
| Oct 22, 2000 | Quarterly Results | - |
| Jul 31, 2000 | Quarterly Results | - |
| Jun 28, 2000 | Accounts | - |
| Jan 31, 2000 | Quarterly Results | - |
| Dec 15, 1999 | Amalgamation & Merger | Amalgamation of Deccan Hospital Corp.Ltd. with the Co. & Preferential Offer |
| Oct 28, 1999 | Quarterly Results | - |
| Jul 15, 1999 | Quarterly Results | - |
| Jun 16, 1999 | Accounts | - |
| Jan 30, 1999 | Quarterly Results | - |
| Jul 29, 1998 | Quarterly Results | - |
| Jun 20, 1998 | Accounts | - |
| Jun 25, 1997 | Accounts. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
04 May 2024
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
as per annexure enclosed
03 May 2024
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Board Meeting Intimation for Approval Of The Annual Audited Standalone Financial Results Of The Company For The Quarter/Year Ended March 31, 2024, The Consolidated Financial Results For The Quarter/ Year Ended March 31, 2024 And Other Important Matters
APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve As per annexure enclosed 
29 Apr 2024
Apollo Hospitals - Deal With Advent A Step Towards Integration Of Retail, Distribution Biz: ICICI Securities
Proceeds will be used for growth, debt repayment and acquisition of 11% stake in Keimed
29 Apr 2024
India's Apollo Hospitals stock slides as unit's valuation underwhelms
The stock trimmed some losses and was last down 4.5 per cent%, set for its worst day since June 2, 2022
27 Apr 2024
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
as per annexure enclosed
27 Apr 2024
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Reg.40(10) - PCS Certificate For Transfer / Transmission / Transposition
Reg.40(10) - PCS Certificate for Transfer / Transmission / Transposition is enclosed
26 Apr 2024
Apollo HealthCo Secures Rs 2,475 Crore Investment From Advent International In Major Deal
Apollo HealthCo Ltd, a subsidiary of Apollo Hospitals Enterprise Ltd, secures Rs 2,475 crore investment from Advent International, forming a joint entity valued at Rs 22,481 crore.
26 Apr 2024
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Subject: Disclosure under Regulation 30 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - revised Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a conference call for the analysts/investors is scheduled to be held on Saturday, 27th April 2024 at 1.30 p.m. regarding update on Apollo Healthco transaction. Pl. find enclosed the details of conference call (revised) for your reference.
